Herpes as an immunity biomarker?
Image credit: https://www.freepik.com/free-photo/businessman-his-office-covering-his-mouth_1201828.htm#page=1&query=covered%20mouth%20business%20man&position=15
Update on HSV vaccine research
- either vaccine doesn’t present enough antigens,
- or the modified virus is so "sick" that it doesn’t work well to generate an immune response.
- potentially good vaccine for HSV-1 (before the infection)
- helps the research on the eradication of the HSV from the nervous system of the host - the importance of region 2
Biological risk and business interference
- HSV-1 infection can rarely lead to more severe complications such as encephalitis (brain infection) or keratitis (eye infection)
- Immunocompromised people can have more severe symptoms and more frequent recurrences
- It enhances the chances of neonatal herpes which can lead to lasting neurologic disability or death in the future newborn
- Infection with HSV-2 increases the risk of acquiring and transmitting HIV infection.
Epigenetic findings on Herpesviruses